Carol Potera. Show Affiliations »
Abstract
Mesh: See more » DNA, Antisense/therapeutic useDrug ApprovalDrug Industry/trendsGene SilencingGenetic Therapy/trendsUnited StatesUnited States Food and Drug Administration
Substances: See more » DNA, Antisense
Year: 2007 PMID: 17483826 DOI: 10.1038/nbt0507-497
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908